Centre for Ocular Research & Education
Waterloo, Ontario, N2L 3G1, Canada
NCT Number: NCT06308666
The purpose of this study is to evaluate the performance of DAILIES TOTAL1 daily disposable contact lenses with regards to subjective symptoms (comfort, dryness, vision) in lens wearers who use identify themselves as substantial digital device users (at least eight hours of digital device use per day).
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Waterloo, Ontario, N2L 3G1, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Daily disposable silicone hydrogel contact lenses indicated for the optical correction of myopia and hyperopia
Other names: DAILIES TOTAL1®
Time frame: Day 14+2
Participants rate their overall comfort after 8 hours or more of digital device use on a scale from 0 (worst) to 100 (best).
Time frame: Day 14+2
Participants rate their overall dryness after 8 hours or more of digital device use on a scale from 0 (worst) to 100 (best).
Time frame: Day 14+2
Participants rate their overall clarity of vision after 8 hours or more of digital device use on a scale from 0 (worst) to 100 (best).
Looking for future studies?
Notify MeUniversity of Waterloo
Other
Acronym: FOX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05320042
Astigmatism, Eye Diseases
Rochester, New York, United States
View Trial DetailsNCT07284966
Astigmatism, Eye Diseases
San Diego, California, United States
View Trial DetailsNCT06817785
Eye Diseases, Myopia
Waterloo, Ontario, Canada
View Trial DetailsNCT07780851
Eye Diseases, Myopia
Singapore
View Trial Details